---
title: "Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286133673.md"
description: "H.C. Wainwright analyst Brandon Folkes has reiterated a Buy rating on Connect Biopharma Holdings (CNTB) with a price target of $7.00. Folkes, a 3-star analyst, has an average return of 2.0% and a 42.07% success rate. The consensus on CNTB is a Strong Buy, with an average price target of $8.38."
datetime: "2026-05-12T16:36:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286133673.md)
  - [en](https://longbridge.com/en/news/286133673.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286133673.md)
---

# Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright

In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings, with a price target of $7.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Folkes is a 3-star analyst with an average return of 2.0% and a 42.07% success rate. Folkes covers the Healthcare sector, focusing on stocks such as Heron Therapeutics, Collegium Pharmaceutical, and Achieve Life Sciences.

Currently, the analyst consensus on Connect Biopharma Holdings is a Strong Buy with an average price target of $8.38.

### Related Stocks

- [CNTB.US](https://longbridge.com/en/quote/CNTB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [HRTX.US](https://longbridge.com/en/quote/HRTX.US.md)
- [COLL.US](https://longbridge.com/en/quote/COLL.US.md)
- [ACHV.US](https://longbridge.com/en/quote/ACHV.US.md)

## Related News & Research

- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md)